Know Cancer

or
forgot password

Transbronchial Needle Forceps for EBUS


Phase 2
18 Years
80 Years
Open (Enrolling)
Both
Lung Cancer, Lymph Nodes

Thank you

Trial Information

Transbronchial Needle Forceps for EBUS


Patients with enlarged mediastinal lymph nodes must be staged. The EBUS TBNA technique is an
established technique. Unfortunately the size of the needle is limited to 21 gauge. With tne
new designed needle forceps it should be possible to obtain more material and establish the
diagnosis more often


Inclusion Criteria:



- enlarged mediastinal lymph nodes

Exclusion Criteria:

- comorbidities

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Number of Participants with a positive biopsy result

Outcome Time Frame:

2 days after intervention

Safety Issue:

No

Principal Investigator

Hendrik Dienemann, PhD, MD

Investigator Role:

Study Director

Investigator Affiliation:

University of Heidelberg

Authority:

Germany: Federal Institute for Drugs and Medical Devices

Study ID:

HD 08

NCT ID:

NCT01145924

Start Date:

January 2010

Completion Date:

August 2010

Related Keywords:

  • Lung Cancer
  • Lymph Nodes
  • bronchoscopy
  • endobronchial ultrasound
  • transbronchial needle aspiration
  • lung cancer
  • staging
  • Lung Neoplasms

Name

Location